Vectorite Biomedical Inc. (TPEX:4170)
Taiwan · Delayed Price · Currency is TWD 12.70
0.00 (0.00%)
Aug 26, 2026, 1:51 PM CST
Vectorite Biomedical Market Cap
Vectorite Biomedical has a market cap or net worth of 555.9 million as of August 26, 2026. Its market cap has decreased by -10.56% in one year.
Market Cap
555.90M
Enterprise Value
390.25M
Revenue
54.81M
Ranking
n/a
PE Ratio
4.79
Stock Price
12.70
ChartMarket Cap Chart
Since April 15, 2013, Vectorite Biomedical's market cap has increased from 393.23M to 555.90M, an increase of 41.37%. That is a compound annual growth rate of 2.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 555.90M | -9.29% |
| Dec 31, 2025 | 612.80M | -3.45% |
| Dec 31, 2024 | 634.68M | -32.08% |
| Dec 29, 2023 | 934.52M | 49.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCI GENE | 899.59M |
| Meribank Biotech | 888.74M |
| Holy Stone Healthcare | 878.76M |
| NatureWise Biotech & Medicals | 781.63M |
| BioLASCO Taiwan | 754.27M |
| SynCore Biotechnology Co.,Ltd | 703.29M |
| Taiwan Advance Bio-Pharmaceutical | 689.40M |
| MegaPro Biomedical | 642.03M |